nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—NME1—breast cancer	0.411	1	CbGaD
Tenofovir—ABCC10—Gemcitabine—breast cancer	0.0478	0.141	CbGbCtD
Tenofovir—ABCC10—Paclitaxel—breast cancer	0.0432	0.127	CbGbCtD
Tenofovir—ABCC10—Docetaxel—breast cancer	0.0312	0.0921	CbGbCtD
Tenofovir—ABCC10—Doxorubicin—breast cancer	0.0233	0.0686	CbGbCtD
Tenofovir—ABCC10—Methotrexate—breast cancer	0.0225	0.0665	CbGbCtD
Tenofovir—ABCC4—Fluorouracil—breast cancer	0.0196	0.0579	CbGbCtD
Tenofovir—CYP1A2—Anastrozole—breast cancer	0.0177	0.0522	CbGbCtD
Tenofovir—CYP1A2—Toremifene—breast cancer	0.0162	0.0477	CbGbCtD
Tenofovir—ABCC2—Tamoxifen—breast cancer	0.0159	0.0468	CbGbCtD
Tenofovir—ABCC2—Paclitaxel—breast cancer	0.0123	0.0364	CbGbCtD
Tenofovir—ABCC2—Irinotecan—breast cancer	0.0122	0.0359	CbGbCtD
Tenofovir—ABCC2—Carboplatin—breast cancer	0.0116	0.0343	CbGbCtD
Tenofovir—ABCC4—Methotrexate—breast cancer	0.0108	0.0319	CbGbCtD
Tenofovir—ABCC2—Vinblastine—breast cancer	0.0108	0.0319	CbGbCtD
Tenofovir—ABCC2—Docetaxel—breast cancer	0.00892	0.0263	CbGbCtD
Tenofovir—SLC22A8—Methotrexate—breast cancer	0.00677	0.02	CbGbCtD
Tenofovir—ABCC2—Doxorubicin—breast cancer	0.00665	0.0196	CbGbCtD
Tenofovir—ABCC2—Methotrexate—breast cancer	0.00644	0.019	CbGbCtD
Tenofovir—CYP1A2—Tamoxifen—breast cancer	0.00591	0.0174	CbGbCtD
Tenofovir—SLC22A6—Methotrexate—breast cancer	0.00471	0.0139	CbGbCtD
Tenofovir—CYP1A2—Fluorouracil—breast cancer	0.00436	0.0128	CbGbCtD
Tenofovir—AK2—mammary gland—breast cancer	0.00269	0.0581	CbGeAlD
Tenofovir—AK4—mammary gland—breast cancer	0.00199	0.0429	CbGeAlD
Tenofovir—AK4—nipple—breast cancer	0.00164	0.0355	CbGeAlD
Tenofovir—NME1-NME2—female reproductive system—breast cancer	0.00147	0.0317	CbGeAlD
Tenofovir—Adefovir Dipivoxil—NME1—breast cancer	0.00135	0.305	CrCbGaD
Tenofovir—NME2—embryo—breast cancer	0.00133	0.0286	CbGeAlD
Tenofovir—NME1—Gefitinib—Lapatinib—breast cancer	0.0013	0.648	CbGdCrCtD
Tenofovir—NME1-NME2—endocrine gland—breast cancer	0.00124	0.0268	CbGeAlD
Tenofovir—AK2—uterus—breast cancer	0.00124	0.0267	CbGeAlD
Tenofovir—AK2—adipose tissue—breast cancer	0.00121	0.0261	CbGeAlD
Tenofovir—NME1—skin of body—breast cancer	0.00109	0.0236	CbGeAlD
Tenofovir—AK2—adrenal gland—breast cancer	0.00109	0.0234	CbGeAlD
Tenofovir—NME2—epithelium—breast cancer	0.00108	0.0234	CbGeAlD
Tenofovir—AK2—bone marrow—breast cancer	0.00105	0.0227	CbGeAlD
Tenofovir—AK2—female gonad—breast cancer	0.00101	0.0219	CbGeAlD
Tenofovir—AK4—endometrium—breast cancer	0.000993	0.0214	CbGeAlD
Tenofovir—NME1—uterus—breast cancer	0.00095	0.0205	CbGeAlD
Tenofovir—NME1—adipose tissue—breast cancer	0.000929	0.0201	CbGeAlD
Tenofovir—AK4—uterus—breast cancer	0.000915	0.0198	CbGeAlD
Tenofovir—AK4—pituitary gland—breast cancer	0.000899	0.0194	CbGeAlD
Tenofovir—AK4—adipose tissue—breast cancer	0.000895	0.0193	CbGeAlD
Tenofovir—NME2—adipose tissue—breast cancer	0.000875	0.0189	CbGeAlD
Tenofovir—NME1-NME2—lymph node—breast cancer	0.000859	0.0185	CbGeAlD
Tenofovir—NME1—female reproductive system—breast cancer	0.000854	0.0184	CbGeAlD
Tenofovir—NME1—adrenal gland—breast cancer	0.000833	0.018	CbGeAlD
Tenofovir—AK4—female reproductive system—breast cancer	0.000823	0.0178	CbGeAlD
Tenofovir—NME1—bone marrow—breast cancer	0.000806	0.0174	CbGeAlD
Tenofovir—NME2—female reproductive system—breast cancer	0.000804	0.0174	CbGeAlD
Tenofovir—AK4—adrenal gland—breast cancer	0.000803	0.0173	CbGeAlD
Tenofovir—NME2—adrenal gland—breast cancer	0.000785	0.0169	CbGeAlD
Tenofovir—ABCC10—nipple—breast cancer	0.00078	0.0169	CbGeAlD
Tenofovir—NME1—female gonad—breast cancer	0.000777	0.0168	CbGeAlD
Tenofovir—AK4—female gonad—breast cancer	0.000749	0.0162	CbGeAlD
Tenofovir—NME2—female gonad—breast cancer	0.000732	0.0158	CbGeAlD
Tenofovir—NME1—endocrine gland—breast cancer	0.000722	0.0156	CbGeAlD
Tenofovir—AK4—endocrine gland—breast cancer	0.000696	0.015	CbGeAlD
Tenofovir—NME2—endocrine gland—breast cancer	0.00068	0.0147	CbGeAlD
Tenofovir—Adenosine triphosphate—ARAF—breast cancer	0.000661	0.149	CrCbGaD
Tenofovir—AK2—lymph node—breast cancer	0.000651	0.0141	CbGeAlD
Tenofovir—NME1—lymph node—breast cancer	0.000499	0.0108	CbGeAlD
Tenofovir—AK4—lymph node—breast cancer	0.000481	0.0104	CbGeAlD
Tenofovir—ABCC10—endometrium—breast cancer	0.000471	0.0102	CbGeAlD
Tenofovir—NME2—lymph node—breast cancer	0.00047	0.0102	CbGeAlD
Tenofovir—CYP1A2—nipple—breast cancer	0.00044	0.0095	CbGeAlD
Tenofovir—Adenosine monophosphate—PIM1—breast cancer	0.000438	0.0987	CrCbGaD
Tenofovir—ABCC10—uterus—breast cancer	0.000434	0.00938	CbGeAlD
Tenofovir—NME1—Loperamide—Toremifene—breast cancer	0.000433	0.216	CbGdCrCtD
Tenofovir—ABCC10—pituitary gland—breast cancer	0.000426	0.00921	CbGeAlD
Tenofovir—ABCC10—adipose tissue—breast cancer	0.000425	0.00917	CbGeAlD
Tenofovir—ABCC10—female reproductive system—breast cancer	0.00039	0.00843	CbGeAlD
Tenofovir—ABCC10—adrenal gland—breast cancer	0.000381	0.00823	CbGeAlD
Tenofovir—Adenosine triphosphate—HSPA1B—breast cancer	0.000379	0.0856	CrCbGaD
Tenofovir—Adenosine monophosphate—APRT—breast cancer	0.000372	0.084	CrCbGaD
Tenofovir—ABCC10—bone marrow—breast cancer	0.000368	0.00796	CbGeAlD
Tenofovir—ABCC4—uterus—breast cancer	0.00036	0.00778	CbGeAlD
Tenofovir—ABCC10—female gonad—breast cancer	0.000355	0.00767	CbGeAlD
Tenofovir—ABCC4—adipose tissue—breast cancer	0.000352	0.00761	CbGeAlD
Tenofovir—ABCC10—endocrine gland—breast cancer	0.00033	0.00713	CbGeAlD
Tenofovir—ABCC4—female reproductive system—breast cancer	0.000324	0.00699	CbGeAlD
Tenofovir—Adenosine triphosphate—ACVR1—breast cancer	0.000323	0.0728	CrCbGaD
Tenofovir—ABCC4—adrenal gland—breast cancer	0.000316	0.00682	CbGeAlD
Tenofovir—ABCC2—female reproductive system—breast cancer	0.000313	0.00677	CbGeAlD
Tenofovir—ABCC2—adrenal gland—breast cancer	0.000306	0.0066	CbGeAlD
Tenofovir—ABCC4—bone marrow—breast cancer	0.000306	0.0066	CbGeAlD
Tenofovir—ABCC4—female gonad—breast cancer	0.000295	0.00636	CbGeAlD
Tenofovir—ABCC4—endocrine gland—breast cancer	0.000274	0.00592	CbGeAlD
Tenofovir—NME1—Loperamide—Tamoxifen—breast cancer	0.000272	0.136	CbGdCrCtD
Tenofovir—ABCC2—endocrine gland—breast cancer	0.000265	0.00573	CbGeAlD
Tenofovir—ABCC10—lymph node—breast cancer	0.000228	0.00493	CbGeAlD
Tenofovir—ABCC4—lymph node—breast cancer	0.000189	0.00409	CbGeAlD
Tenofovir—CYP1A2—endocrine gland—breast cancer	0.000186	0.00402	CbGeAlD
Tenofovir—ABCC2—lymph node—breast cancer	0.000183	0.00396	CbGeAlD
Tenofovir—Adenosine triphosphate—ALK—breast cancer	0.000174	0.0393	CrCbGaD
Tenofovir—S-Adenosylmethionine—COMT—breast cancer	0.000158	0.0356	CrCbGaD
Tenofovir—Adenosine monophosphate—PDE4D—breast cancer	0.000153	0.0346	CrCbGaD
Tenofovir—Adenosine triphosphate—AKT1—breast cancer	0.000136	0.0307	CrCbGaD
Tenofovir—Adenosine monophosphate—SRC—breast cancer	0.000134	0.0303	CrCbGaD
Tenofovir—Adenosine triphosphate—ABL1—breast cancer	0.000128	0.029	CrCbGaD
Tenofovir—Infestation—Epirubicin—breast cancer	4.79e-05	0.000408	CcSEcCtD
Tenofovir—Rash—Thiotepa—breast cancer	4.79e-05	0.000408	CcSEcCtD
Tenofovir—Dermatitis—Thiotepa—breast cancer	4.78e-05	0.000407	CcSEcCtD
Tenofovir—Dyspnoea—Paclitaxel—breast cancer	4.77e-05	0.000406	CcSEcCtD
Tenofovir—Headache—Thiotepa—breast cancer	4.76e-05	0.000405	CcSEcCtD
Tenofovir—Myalgia—Docetaxel—breast cancer	4.73e-05	0.000403	CcSEcCtD
Tenofovir—Arthralgia—Docetaxel—breast cancer	4.73e-05	0.000403	CcSEcCtD
Tenofovir—Chest pain—Docetaxel—breast cancer	4.73e-05	0.000403	CcSEcCtD
Tenofovir—Nausea—Vinorelbine—breast cancer	4.72e-05	0.000402	CcSEcCtD
Tenofovir—Renal failure—Epirubicin—breast cancer	4.71e-05	0.000401	CcSEcCtD
Tenofovir—Dyspepsia—Paclitaxel—breast cancer	4.71e-05	0.000401	CcSEcCtD
Tenofovir—Asthenia—Mitoxantrone—breast cancer	4.7e-05	0.000401	CcSEcCtD
Tenofovir—Asthenia—Irinotecan—breast cancer	4.7e-05	0.000401	CcSEcCtD
Tenofovir—Neuropathy peripheral—Epirubicin—breast cancer	4.7e-05	0.0004	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	4.7e-05	0.0004	CcSEcCtD
Tenofovir—Decreased appetite—Paclitaxel—breast cancer	4.65e-05	0.000396	CcSEcCtD
Tenofovir—Hypersensitivity—Fluorouracil—breast cancer	4.63e-05	0.000394	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Doxorubicin—breast cancer	4.62e-05	0.000394	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Paclitaxel—breast cancer	4.62e-05	0.000393	CcSEcCtD
Tenofovir—Fatigue—Paclitaxel—breast cancer	4.61e-05	0.000393	CcSEcCtD
Tenofovir—Hepatitis—Methotrexate—breast cancer	4.6e-05	0.000392	CcSEcCtD
Tenofovir—Sweating—Epirubicin—breast cancer	4.6e-05	0.000391	CcSEcCtD
Tenofovir—Asthenia—Gemcitabine—breast cancer	4.58e-05	0.00039	CcSEcCtD
Tenofovir—Chest pain—Capecitabine—breast cancer	4.58e-05	0.00039	CcSEcCtD
Tenofovir—Arthralgia—Capecitabine—breast cancer	4.58e-05	0.00039	CcSEcCtD
Tenofovir—Myalgia—Capecitabine—breast cancer	4.58e-05	0.00039	CcSEcCtD
Tenofovir—Pain—Paclitaxel—breast cancer	4.57e-05	0.000389	CcSEcCtD
Tenofovir—Haematuria—Epirubicin—breast cancer	4.57e-05	0.000389	CcSEcCtD
Tenofovir—Anxiety—Capecitabine—breast cancer	4.56e-05	0.000388	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	4.55e-05	0.000387	CcSEcCtD
Tenofovir—Urinary tract disorder—Methotrexate—breast cancer	4.54e-05	0.000387	CcSEcCtD
Tenofovir—Hepatobiliary disease—Epirubicin—breast cancer	4.53e-05	0.000386	CcSEcCtD
Tenofovir—Pruritus—Gemcitabine—breast cancer	4.52e-05	0.000385	CcSEcCtD
Tenofovir—Nausea—Thiotepa—breast cancer	4.51e-05	0.000384	CcSEcCtD
Tenofovir—Urethral disorder—Methotrexate—breast cancer	4.51e-05	0.000384	CcSEcCtD
Tenofovir—Weight decreased—Doxorubicin—breast cancer	4.5e-05	0.000383	CcSEcCtD
Tenofovir—Sinusitis—Epirubicin—breast cancer	4.5e-05	0.000383	CcSEcCtD
Tenofovir—Hyperglycaemia—Doxorubicin—breast cancer	4.49e-05	0.000382	CcSEcCtD
Tenofovir—Diarrhoea—Mitoxantrone—breast cancer	4.49e-05	0.000382	CcSEcCtD
Tenofovir—Diarrhoea—Irinotecan—breast cancer	4.49e-05	0.000382	CcSEcCtD
Tenofovir—Pneumonia—Doxorubicin—breast cancer	4.46e-05	0.00038	CcSEcCtD
Tenofovir—Nervous system disorder—Docetaxel—breast cancer	4.44e-05	0.000378	CcSEcCtD
Tenofovir—Pruritus—Fluorouracil—breast cancer	4.44e-05	0.000378	CcSEcCtD
Tenofovir—Infestation—Doxorubicin—breast cancer	4.44e-05	0.000378	CcSEcCtD
Tenofovir—Infestation NOS—Doxorubicin—breast cancer	4.44e-05	0.000378	CcSEcCtD
Tenofovir—Skin disorder—Docetaxel—breast cancer	4.4e-05	0.000375	CcSEcCtD
Tenofovir—Gastrointestinal pain—Paclitaxel—breast cancer	4.37e-05	0.000372	CcSEcCtD
Tenofovir—Diarrhoea—Gemcitabine—breast cancer	4.37e-05	0.000372	CcSEcCtD
Tenofovir—Renal failure—Doxorubicin—breast cancer	4.36e-05	0.000371	CcSEcCtD
Tenofovir—Neuropathy peripheral—Doxorubicin—breast cancer	4.35e-05	0.00037	CcSEcCtD
Tenofovir—Dizziness—Irinotecan—breast cancer	4.34e-05	0.000369	CcSEcCtD
Tenofovir—Anorexia—Docetaxel—breast cancer	4.32e-05	0.000368	CcSEcCtD
Tenofovir—Nervous system disorder—Capecitabine—breast cancer	4.3e-05	0.000366	CcSEcCtD
Tenofovir—Hepatitis—Epirubicin—breast cancer	4.3e-05	0.000366	CcSEcCtD
Tenofovir—Diarrhoea—Fluorouracil—breast cancer	4.3e-05	0.000366	CcSEcCtD
Tenofovir—Skin disorder—Capecitabine—breast cancer	4.26e-05	0.000363	CcSEcCtD
Tenofovir—Sweating—Doxorubicin—breast cancer	4.25e-05	0.000362	CcSEcCtD
Tenofovir—Urinary tract disorder—Epirubicin—breast cancer	4.25e-05	0.000362	CcSEcCtD
Tenofovir—Hyperhidrosis—Capecitabine—breast cancer	4.24e-05	0.000361	CcSEcCtD
Tenofovir—Haematuria—Doxorubicin—breast cancer	4.23e-05	0.00036	CcSEcCtD
Tenofovir—Connective tissue disorder—Epirubicin—breast cancer	4.23e-05	0.00036	CcSEcCtD
Tenofovir—Abdominal pain—Paclitaxel—breast cancer	4.23e-05	0.00036	CcSEcCtD
Tenofovir—Body temperature increased—Paclitaxel—breast cancer	4.23e-05	0.00036	CcSEcCtD
Tenofovir—Urethral disorder—Epirubicin—breast cancer	4.22e-05	0.000359	CcSEcCtD
Tenofovir—Hepatobiliary disease—Doxorubicin—breast cancer	4.19e-05	0.000357	CcSEcCtD
Tenofovir—Anorexia—Capecitabine—breast cancer	4.18e-05	0.000356	CcSEcCtD
Tenofovir—Vomiting—Mitoxantrone—breast cancer	4.17e-05	0.000355	CcSEcCtD
Tenofovir—Vomiting—Irinotecan—breast cancer	4.17e-05	0.000355	CcSEcCtD
Tenofovir—Sinusitis—Doxorubicin—breast cancer	4.16e-05	0.000354	CcSEcCtD
Tenofovir—Immune system disorder—Methotrexate—breast cancer	4.15e-05	0.000354	CcSEcCtD
Tenofovir—Dizziness—Fluorouracil—breast cancer	4.15e-05	0.000354	CcSEcCtD
Tenofovir—Mediastinal disorder—Methotrexate—breast cancer	4.14e-05	0.000353	CcSEcCtD
Tenofovir—Rash—Irinotecan—breast cancer	4.13e-05	0.000352	CcSEcCtD
Tenofovir—Rash—Mitoxantrone—breast cancer	4.13e-05	0.000352	CcSEcCtD
Tenofovir—Dermatitis—Mitoxantrone—breast cancer	4.13e-05	0.000352	CcSEcCtD
Tenofovir—Dermatitis—Irinotecan—breast cancer	4.13e-05	0.000352	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Docetaxel—breast cancer	4.13e-05	0.000352	CcSEcCtD
Tenofovir—Headache—Mitoxantrone—breast cancer	4.11e-05	0.00035	CcSEcCtD
Tenofovir—Headache—Irinotecan—breast cancer	4.11e-05	0.00035	CcSEcCtD
Tenofovir—Insomnia—Docetaxel—breast cancer	4.1e-05	0.000349	CcSEcCtD
Tenofovir—Vomiting—Gemcitabine—breast cancer	4.06e-05	0.000346	CcSEcCtD
Tenofovir—Dyspnoea—Docetaxel—breast cancer	4.04e-05	0.000344	CcSEcCtD
Tenofovir—Mental disorder—Methotrexate—breast cancer	4.03e-05	0.000343	CcSEcCtD
Tenofovir—Rash—Gemcitabine—breast cancer	4.03e-05	0.000343	CcSEcCtD
Tenofovir—Dermatitis—Gemcitabine—breast cancer	4.02e-05	0.000343	CcSEcCtD
Tenofovir—Malnutrition—Methotrexate—breast cancer	4e-05	0.000341	CcSEcCtD
Tenofovir—Headache—Gemcitabine—breast cancer	4e-05	0.000341	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Capecitabine—breast cancer	4e-05	0.00034	CcSEcCtD
Tenofovir—Vomiting—Fluorouracil—breast cancer	3.99e-05	0.00034	CcSEcCtD
Tenofovir—Dyspepsia—Docetaxel—breast cancer	3.99e-05	0.00034	CcSEcCtD
Tenofovir—Hepatitis—Doxorubicin—breast cancer	3.98e-05	0.000339	CcSEcCtD
Tenofovir—Insomnia—Capecitabine—breast cancer	3.97e-05	0.000338	CcSEcCtD
Tenofovir—Rash—Fluorouracil—breast cancer	3.96e-05	0.000337	CcSEcCtD
Tenofovir—Dermatitis—Fluorouracil—breast cancer	3.96e-05	0.000337	CcSEcCtD
Tenofovir—Decreased appetite—Docetaxel—breast cancer	3.94e-05	0.000336	CcSEcCtD
Tenofovir—Hypersensitivity—Paclitaxel—breast cancer	3.94e-05	0.000335	CcSEcCtD
Tenofovir—Headache—Fluorouracil—breast cancer	3.93e-05	0.000335	CcSEcCtD
Tenofovir—Urinary tract disorder—Doxorubicin—breast cancer	3.93e-05	0.000335	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Docetaxel—breast cancer	3.91e-05	0.000333	CcSEcCtD
Tenofovir—Connective tissue disorder—Doxorubicin—breast cancer	3.91e-05	0.000333	CcSEcCtD
Tenofovir—Dyspnoea—Capecitabine—breast cancer	3.91e-05	0.000333	CcSEcCtD
Tenofovir—Fatigue—Docetaxel—breast cancer	3.91e-05	0.000333	CcSEcCtD
Tenofovir—Urethral disorder—Doxorubicin—breast cancer	3.9e-05	0.000332	CcSEcCtD
Tenofovir—Nausea—Irinotecan—breast cancer	3.89e-05	0.000332	CcSEcCtD
Tenofovir—Nausea—Mitoxantrone—breast cancer	3.89e-05	0.000332	CcSEcCtD
Tenofovir—Immune system disorder—Epirubicin—breast cancer	3.89e-05	0.000331	CcSEcCtD
Tenofovir—Mediastinal disorder—Epirubicin—breast cancer	3.88e-05	0.00033	CcSEcCtD
Tenofovir—Pain—Docetaxel—breast cancer	3.88e-05	0.00033	CcSEcCtD
Tenofovir—Back pain—Methotrexate—breast cancer	3.87e-05	0.00033	CcSEcCtD
Tenofovir—Dyspepsia—Capecitabine—breast cancer	3.86e-05	0.000329	CcSEcCtD
Tenofovir—Asthenia—Paclitaxel—breast cancer	3.84e-05	0.000327	CcSEcCtD
Tenofovir—Decreased appetite—Capecitabine—breast cancer	3.81e-05	0.000325	CcSEcCtD
Tenofovir—Nausea—Gemcitabine—breast cancer	3.79e-05	0.000323	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Capecitabine—breast cancer	3.79e-05	0.000323	CcSEcCtD
Tenofovir—Fatigue—Capecitabine—breast cancer	3.78e-05	0.000322	CcSEcCtD
Tenofovir—Pruritus—Paclitaxel—breast cancer	3.78e-05	0.000322	CcSEcCtD
Tenofovir—Mental disorder—Epirubicin—breast cancer	3.77e-05	0.000321	CcSEcCtD
Tenofovir—Pain—Capecitabine—breast cancer	3.75e-05	0.00032	CcSEcCtD
Tenofovir—Malnutrition—Epirubicin—breast cancer	3.75e-05	0.000319	CcSEcCtD
Tenofovir—Nausea—Fluorouracil—breast cancer	3.73e-05	0.000318	CcSEcCtD
Tenofovir—Gastrointestinal pain—Docetaxel—breast cancer	3.71e-05	0.000316	CcSEcCtD
Tenofovir—Flatulence—Epirubicin—breast cancer	3.69e-05	0.000314	CcSEcCtD
Tenofovir—Diarrhoea—Paclitaxel—breast cancer	3.66e-05	0.000312	CcSEcCtD
Tenofovir—Back pain—Epirubicin—breast cancer	3.62e-05	0.000309	CcSEcCtD
Tenofovir—Immune system disorder—Doxorubicin—breast cancer	3.6e-05	0.000306	CcSEcCtD
Tenofovir—Gastrointestinal pain—Capecitabine—breast cancer	3.59e-05	0.000306	CcSEcCtD
Tenofovir—Mediastinal disorder—Doxorubicin—breast cancer	3.59e-05	0.000306	CcSEcCtD
Tenofovir—Abdominal pain—Docetaxel—breast cancer	3.58e-05	0.000305	CcSEcCtD
Tenofovir—Body temperature increased—Docetaxel—breast cancer	3.58e-05	0.000305	CcSEcCtD
Tenofovir—Dizziness—Paclitaxel—breast cancer	3.54e-05	0.000301	CcSEcCtD
Tenofovir—Mental disorder—Doxorubicin—breast cancer	3.49e-05	0.000297	CcSEcCtD
Tenofovir—Body temperature increased—Capecitabine—breast cancer	3.47e-05	0.000295	CcSEcCtD
Tenofovir—Abdominal pain—Capecitabine—breast cancer	3.47e-05	0.000295	CcSEcCtD
Tenofovir—Malnutrition—Doxorubicin—breast cancer	3.47e-05	0.000295	CcSEcCtD
Tenofovir—Flatulence—Doxorubicin—breast cancer	3.42e-05	0.000291	CcSEcCtD
Tenofovir—Chest pain—Methotrexate—breast cancer	3.41e-05	0.00029	CcSEcCtD
Tenofovir—Myalgia—Methotrexate—breast cancer	3.41e-05	0.00029	CcSEcCtD
Tenofovir—Arthralgia—Methotrexate—breast cancer	3.41e-05	0.00029	CcSEcCtD
Tenofovir—Vomiting—Paclitaxel—breast cancer	3.4e-05	0.00029	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.38e-05	0.000288	CcSEcCtD
Tenofovir—Rash—Paclitaxel—breast cancer	3.37e-05	0.000287	CcSEcCtD
Tenofovir—Dermatitis—Paclitaxel—breast cancer	3.37e-05	0.000287	CcSEcCtD
Tenofovir—Back pain—Doxorubicin—breast cancer	3.35e-05	0.000285	CcSEcCtD
Tenofovir—Headache—Paclitaxel—breast cancer	3.35e-05	0.000285	CcSEcCtD
Tenofovir—Hypersensitivity—Docetaxel—breast cancer	3.34e-05	0.000284	CcSEcCtD
Tenofovir—Asthenia—Docetaxel—breast cancer	3.25e-05	0.000277	CcSEcCtD
Tenofovir—Hypersensitivity—Capecitabine—breast cancer	3.23e-05	0.000275	CcSEcCtD
Tenofovir—Pruritus—Docetaxel—breast cancer	3.21e-05	0.000273	CcSEcCtD
Tenofovir—Nervous system disorder—Methotrexate—breast cancer	3.2e-05	0.000273	CcSEcCtD
Tenofovir—Arthralgia—Epirubicin—breast cancer	3.19e-05	0.000272	CcSEcCtD
Tenofovir—Myalgia—Epirubicin—breast cancer	3.19e-05	0.000272	CcSEcCtD
Tenofovir—Chest pain—Epirubicin—breast cancer	3.19e-05	0.000272	CcSEcCtD
Tenofovir—Anxiety—Epirubicin—breast cancer	3.18e-05	0.000271	CcSEcCtD
Tenofovir—Nausea—Paclitaxel—breast cancer	3.18e-05	0.00027	CcSEcCtD
Tenofovir—Skin disorder—Methotrexate—breast cancer	3.17e-05	0.00027	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.17e-05	0.00027	CcSEcCtD
Tenofovir—Hyperhidrosis—Methotrexate—breast cancer	3.16e-05	0.000269	CcSEcCtD
Tenofovir—Asthenia—Capecitabine—breast cancer	3.15e-05	0.000268	CcSEcCtD
Tenofovir—Anorexia—Methotrexate—breast cancer	3.11e-05	0.000265	CcSEcCtD
Tenofovir—Pruritus—Capecitabine—breast cancer	3.1e-05	0.000264	CcSEcCtD
Tenofovir—Diarrhoea—Docetaxel—breast cancer	3.1e-05	0.000264	CcSEcCtD
Tenofovir—Diarrhoea—Capecitabine—breast cancer	3e-05	0.000256	CcSEcCtD
Tenofovir—Nervous system disorder—Epirubicin—breast cancer	3e-05	0.000255	CcSEcCtD
Tenofovir—Dizziness—Docetaxel—breast cancer	3e-05	0.000255	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Methotrexate—breast cancer	2.98e-05	0.000253	CcSEcCtD
Tenofovir—Skin disorder—Epirubicin—breast cancer	2.97e-05	0.000253	CcSEcCtD
Tenofovir—Hyperhidrosis—Epirubicin—breast cancer	2.96e-05	0.000252	CcSEcCtD
Tenofovir—Insomnia—Methotrexate—breast cancer	2.95e-05	0.000252	CcSEcCtD
Tenofovir—Arthralgia—Doxorubicin—breast cancer	2.95e-05	0.000251	CcSEcCtD
Tenofovir—Chest pain—Doxorubicin—breast cancer	2.95e-05	0.000251	CcSEcCtD
Tenofovir—Myalgia—Doxorubicin—breast cancer	2.95e-05	0.000251	CcSEcCtD
Tenofovir—Anxiety—Doxorubicin—breast cancer	2.94e-05	0.00025	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.93e-05	0.00025	CcSEcCtD
Tenofovir—Anorexia—Epirubicin—breast cancer	2.91e-05	0.000248	CcSEcCtD
Tenofovir—Dyspnoea—Methotrexate—breast cancer	2.91e-05	0.000248	CcSEcCtD
Tenofovir—Dizziness—Capecitabine—breast cancer	2.9e-05	0.000247	CcSEcCtD
Tenofovir—Vomiting—Docetaxel—breast cancer	2.88e-05	0.000245	CcSEcCtD
Tenofovir—Dyspepsia—Methotrexate—breast cancer	2.88e-05	0.000245	CcSEcCtD
Tenofovir—Rash—Docetaxel—breast cancer	2.86e-05	0.000243	CcSEcCtD
Tenofovir—Dermatitis—Docetaxel—breast cancer	2.86e-05	0.000243	CcSEcCtD
Tenofovir—Decreased appetite—Methotrexate—breast cancer	2.84e-05	0.000242	CcSEcCtD
Tenofovir—Headache—Docetaxel—breast cancer	2.84e-05	0.000242	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Methotrexate—breast cancer	2.82e-05	0.00024	CcSEcCtD
Tenofovir—Fatigue—Methotrexate—breast cancer	2.82e-05	0.00024	CcSEcCtD
Tenofovir—Pain—Methotrexate—breast cancer	2.79e-05	0.000238	CcSEcCtD
Tenofovir—Vomiting—Capecitabine—breast cancer	2.79e-05	0.000238	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Epirubicin—breast cancer	2.79e-05	0.000237	CcSEcCtD
Tenofovir—Nervous system disorder—Doxorubicin—breast cancer	2.77e-05	0.000236	CcSEcCtD
Tenofovir—Rash—Capecitabine—breast cancer	2.77e-05	0.000236	CcSEcCtD
Tenofovir—Insomnia—Epirubicin—breast cancer	2.77e-05	0.000235	CcSEcCtD
Tenofovir—Dermatitis—Capecitabine—breast cancer	2.76e-05	0.000235	CcSEcCtD
Tenofovir—Headache—Capecitabine—breast cancer	2.75e-05	0.000234	CcSEcCtD
Tenofovir—Skin disorder—Doxorubicin—breast cancer	2.75e-05	0.000234	CcSEcCtD
Tenofovir—Hyperhidrosis—Doxorubicin—breast cancer	2.73e-05	0.000233	CcSEcCtD
Tenofovir—Dyspnoea—Epirubicin—breast cancer	2.73e-05	0.000232	CcSEcCtD
Tenofovir—Anorexia—Doxorubicin—breast cancer	2.7e-05	0.00023	CcSEcCtD
Tenofovir—Nausea—Docetaxel—breast cancer	2.69e-05	0.000229	CcSEcCtD
Tenofovir—Dyspepsia—Epirubicin—breast cancer	2.69e-05	0.000229	CcSEcCtD
Tenofovir—Gastrointestinal pain—Methotrexate—breast cancer	2.67e-05	0.000227	CcSEcCtD
Tenofovir—Decreased appetite—Epirubicin—breast cancer	2.66e-05	0.000226	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Epirubicin—breast cancer	2.64e-05	0.000225	CcSEcCtD
Tenofovir—Fatigue—Epirubicin—breast cancer	2.64e-05	0.000224	CcSEcCtD
Tenofovir—Pain—Epirubicin—breast cancer	2.61e-05	0.000223	CcSEcCtD
Tenofovir—Nausea—Capecitabine—breast cancer	2.61e-05	0.000222	CcSEcCtD
Tenofovir—Abdominal pain—Methotrexate—breast cancer	2.58e-05	0.00022	CcSEcCtD
Tenofovir—Body temperature increased—Methotrexate—breast cancer	2.58e-05	0.00022	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.58e-05	0.000219	CcSEcCtD
Tenofovir—Insomnia—Doxorubicin—breast cancer	2.56e-05	0.000218	CcSEcCtD
Tenofovir—Dyspnoea—Doxorubicin—breast cancer	2.52e-05	0.000215	CcSEcCtD
Tenofovir—Gastrointestinal pain—Epirubicin—breast cancer	2.5e-05	0.000213	CcSEcCtD
Tenofovir—Dyspepsia—Doxorubicin—breast cancer	2.49e-05	0.000212	CcSEcCtD
Tenofovir—Decreased appetite—Doxorubicin—breast cancer	2.46e-05	0.000209	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Doxorubicin—breast cancer	2.44e-05	0.000208	CcSEcCtD
Tenofovir—Fatigue—Doxorubicin—breast cancer	2.44e-05	0.000208	CcSEcCtD
Tenofovir—Pain—Doxorubicin—breast cancer	2.42e-05	0.000206	CcSEcCtD
Tenofovir—Abdominal pain—Epirubicin—breast cancer	2.42e-05	0.000206	CcSEcCtD
Tenofovir—Body temperature increased—Epirubicin—breast cancer	2.42e-05	0.000206	CcSEcCtD
Tenofovir—Hypersensitivity—Methotrexate—breast cancer	2.41e-05	0.000205	CcSEcCtD
Tenofovir—Adenosine triphosphate—ABCB1—breast cancer	2.38e-05	0.00536	CrCbGaD
Tenofovir—Asthenia—Methotrexate—breast cancer	2.34e-05	0.0002	CcSEcCtD
Tenofovir—Gastrointestinal pain—Doxorubicin—breast cancer	2.31e-05	0.000197	CcSEcCtD
Tenofovir—Pruritus—Methotrexate—breast cancer	2.31e-05	0.000197	CcSEcCtD
Tenofovir—Hypersensitivity—Epirubicin—breast cancer	2.25e-05	0.000192	CcSEcCtD
Tenofovir—Abdominal pain—Doxorubicin—breast cancer	2.24e-05	0.00019	CcSEcCtD
Tenofovir—Body temperature increased—Doxorubicin—breast cancer	2.24e-05	0.00019	CcSEcCtD
Tenofovir—Diarrhoea—Methotrexate—breast cancer	2.24e-05	0.00019	CcSEcCtD
Tenofovir—Asthenia—Epirubicin—breast cancer	2.19e-05	0.000187	CcSEcCtD
Tenofovir—Pruritus—Epirubicin—breast cancer	2.16e-05	0.000184	CcSEcCtD
Tenofovir—Dizziness—Methotrexate—breast cancer	2.16e-05	0.000184	CcSEcCtD
Tenofovir—Diarrhoea—Epirubicin—breast cancer	2.09e-05	0.000178	CcSEcCtD
Tenofovir—Hypersensitivity—Doxorubicin—breast cancer	2.08e-05	0.000177	CcSEcCtD
Tenofovir—Vomiting—Methotrexate—breast cancer	2.08e-05	0.000177	CcSEcCtD
Tenofovir—Rash—Methotrexate—breast cancer	2.06e-05	0.000175	CcSEcCtD
Tenofovir—Dermatitis—Methotrexate—breast cancer	2.06e-05	0.000175	CcSEcCtD
Tenofovir—Headache—Methotrexate—breast cancer	2.05e-05	0.000174	CcSEcCtD
Tenofovir—Asthenia—Doxorubicin—breast cancer	2.03e-05	0.000173	CcSEcCtD
Tenofovir—Dizziness—Epirubicin—breast cancer	2.02e-05	0.000172	CcSEcCtD
Tenofovir—Pruritus—Doxorubicin—breast cancer	2e-05	0.00017	CcSEcCtD
Tenofovir—Vomiting—Epirubicin—breast cancer	1.94e-05	0.000166	CcSEcCtD
Tenofovir—Nausea—Methotrexate—breast cancer	1.94e-05	0.000165	CcSEcCtD
Tenofovir—Diarrhoea—Doxorubicin—breast cancer	1.94e-05	0.000165	CcSEcCtD
Tenofovir—Rash—Epirubicin—breast cancer	1.93e-05	0.000164	CcSEcCtD
Tenofovir—Dermatitis—Epirubicin—breast cancer	1.93e-05	0.000164	CcSEcCtD
Tenofovir—Headache—Epirubicin—breast cancer	1.92e-05	0.000163	CcSEcCtD
Tenofovir—Dizziness—Doxorubicin—breast cancer	1.87e-05	0.000159	CcSEcCtD
Tenofovir—Nausea—Epirubicin—breast cancer	1.82e-05	0.000155	CcSEcCtD
Tenofovir—Vomiting—Doxorubicin—breast cancer	1.8e-05	0.000153	CcSEcCtD
Tenofovir—Rash—Doxorubicin—breast cancer	1.78e-05	0.000152	CcSEcCtD
Tenofovir—Dermatitis—Doxorubicin—breast cancer	1.78e-05	0.000152	CcSEcCtD
Tenofovir—Headache—Doxorubicin—breast cancer	1.77e-05	0.000151	CcSEcCtD
Tenofovir—Nausea—Doxorubicin—breast cancer	1.68e-05	0.000143	CcSEcCtD
Tenofovir—NME1—Metabolism—NCOR1—breast cancer	1.26e-05	0.000157	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP2D6—breast cancer	1.26e-05	0.000157	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—NCOA1—breast cancer	1.25e-05	0.000156	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—TFRC—breast cancer	1.25e-05	0.000155	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ITPR1—breast cancer	1.24e-05	0.000155	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP2D6—breast cancer	1.24e-05	0.000154	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—NCOA2—breast cancer	1.24e-05	0.000154	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ABL1—breast cancer	1.23e-05	0.000154	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—NCOA2—breast cancer	1.23e-05	0.000154	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—breast cancer	1.23e-05	0.000154	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CG—breast cancer	1.23e-05	0.000154	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—PLG—breast cancer	1.22e-05	0.000152	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GPX1—breast cancer	1.2e-05	0.00015	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—NCOA2—breast cancer	1.2e-05	0.00015	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—NCOA1—breast cancer	1.2e-05	0.000149	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP1A1—breast cancer	1.19e-05	0.000149	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ERCC2—breast cancer	1.18e-05	0.000147	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.18e-05	0.000147	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTEN—breast cancer	1.18e-05	0.000147	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IL2—breast cancer	1.18e-05	0.000147	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—PLG—breast cancer	1.17e-05	0.000146	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PLA2G4A—breast cancer	1.16e-05	0.000145	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HGF—breast cancer	1.16e-05	0.000145	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CSF2—breast cancer	1.15e-05	0.000143	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.14e-05	0.000143	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.14e-05	0.000142	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—breast cancer	1.14e-05	0.000142	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—SRC—breast cancer	1.14e-05	0.000142	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—breast cancer	1.12e-05	0.00014	CbGpPWpGaD
Tenofovir—NME1—Metabolism—MTHFR—breast cancer	1.11e-05	0.000138	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—breast cancer	1.11e-05	0.000138	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—ALB—breast cancer	1.11e-05	0.000138	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP3A4—breast cancer	1.11e-05	0.000138	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.1e-05	0.000138	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP3A4—breast cancer	1.09e-05	0.000136	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP1B1—breast cancer	1.09e-05	0.000136	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	1.09e-05	0.000136	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CD—breast cancer	1.08e-05	0.000135	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—breast cancer	1.08e-05	0.000135	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—HMOX1—breast cancer	1.08e-05	0.000134	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—TGFB1—breast cancer	1.08e-05	0.000134	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP1B1—breast cancer	1.07e-05	0.000134	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ALB—breast cancer	1.07e-05	0.000133	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—NCOA1—breast cancer	1.04e-05	0.00013	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—NCOA1—breast cancer	1.04e-05	0.00013	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ABCB1—breast cancer	1.03e-05	0.000129	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—SRC—breast cancer	1.03e-05	0.000128	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CAV1—breast cancer	1.02e-05	0.000128	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP19A1—breast cancer	1.02e-05	0.000128	CbGpPWpGaD
Tenofovir—NME2—Metabolism—NOS3—breast cancer	1.02e-05	0.000127	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—breast cancer	1.02e-05	0.000127	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—breast cancer	1.02e-05	0.000127	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	1.02e-05	0.000127	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—NCOA1—breast cancer	1.01e-05	0.000126	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP19A1—breast cancer	1.01e-05	0.000126	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—breast cancer	9.99e-06	0.000125	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—breast cancer	9.99e-06	0.000125	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—breast cancer	9.99e-06	0.000125	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	9.87e-06	0.000123	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	9.87e-06	0.000123	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MMP1—breast cancer	9.86e-06	0.000123	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—PLG—breast cancer	9.85e-06	0.000123	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CDK2—breast cancer	9.68e-06	0.000121	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PLAU—breast cancer	9.68e-06	0.000121	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—COMT—breast cancer	9.52e-06	0.000119	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—breast cancer	9.51e-06	0.000119	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—breast cancer	9.51e-06	0.000119	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTP1—breast cancer	9.47e-06	0.000118	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CAV1—breast cancer	9.45e-06	0.000118	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—MAPK3—breast cancer	9.45e-06	0.000118	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—breast cancer	9.44e-06	0.000118	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CB—breast cancer	9.43e-06	0.000118	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—COMT—breast cancer	9.38e-06	0.000117	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	9.38e-06	0.000117	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—HADHB—breast cancer	9.36e-06	0.000117	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS2—breast cancer	9.35e-06	0.000117	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTP1—breast cancer	9.34e-06	0.000116	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CG—breast cancer	9.33e-06	0.000116	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—breast cancer	9.17e-06	0.000114	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—HMOX1—breast cancer	9.09e-06	0.000113	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	9e-06	0.000112	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—FN1—breast cancer	9e-06	0.000112	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NOS2—breast cancer	8.89e-06	0.000111	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ABCB1—breast cancer	8.72e-06	0.000109	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTM1—breast cancer	8.7e-06	0.000109	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CG—breast cancer	8.61e-06	0.000107	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTM1—breast cancer	8.58e-06	0.000107	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—breast cancer	8.56e-06	0.000107	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—EGF—breast cancer	8.51e-06	0.000106	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CA—breast cancer	8.29e-06	0.000103	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP1A1—breast cancer	8.25e-06	0.000103	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CD—breast cancer	8.2e-06	0.000102	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTEN—breast cancer	8.15e-06	0.000102	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP1A1—breast cancer	8.14e-06	0.000101	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ALB—breast cancer	8.1e-06	0.000101	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—breast cancer	8.02e-06	0.0001	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	7.96e-06	9.92e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IGF1—breast cancer	7.89e-06	9.83e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—AKT2—breast cancer	7.88e-06	9.83e-05	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	7.8e-06	9.73e-05	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NOS3—breast cancer	7.74e-06	9.66e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	7.71e-06	9.61e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CD—breast cancer	7.57e-06	9.44e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SERPINE1—breast cancer	7.49e-06	9.34e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ALB—breast cancer	7.47e-06	9.32e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NOS3—breast cancer	7.15e-06	8.92e-05	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CB—breast cancer	7.15e-06	8.91e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—GPX2—breast cancer	7.09e-06	8.85e-05	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS2—breast cancer	7.08e-06	8.83e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—breast cancer	7.01e-06	8.74e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—breast cancer	6.84e-06	8.53e-05	CbGpPWpGaD
Tenofovir—AK2—Metabolism—AKT1—breast cancer	6.78e-06	8.45e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—RAF1—breast cancer	6.76e-06	8.43e-05	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ALB—breast cancer	6.75e-06	8.42e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SYNJ2—breast cancer	6.64e-06	8.28e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CB—breast cancer	6.6e-06	8.23e-05	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ALB—breast cancer	6.47e-06	8.07e-05	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—AKT1—breast cancer	6.38e-06	7.95e-05	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTEN—breast cancer	6.18e-06	7.7e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NDUFS3—breast cancer	6.17e-06	7.7e-05	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	6.1e-06	7.61e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IL2—breast cancer	6.06e-06	7.56e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—MED12—breast cancer	5.93e-06	7.4e-05	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—RAF1—breast cancer	5.85e-06	7.3e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CHST9—breast cancer	5.8e-06	7.24e-05	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CA—breast cancer	5.75e-06	7.17e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	5.67e-06	7.07e-05	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	5.63e-06	7.02e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	5.52e-06	6.88e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—COX11—breast cancer	5.5e-06	6.86e-05	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ALB—breast cancer	5.46e-06	6.8e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	5.41e-06	6.75e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SRC—breast cancer	5.29e-06	6.59e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—breast cancer	5.25e-06	6.54e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFA—breast cancer	5.15e-06	6.42e-05	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	5.09e-06	6.35e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SHMT1—breast cancer	5.03e-06	6.27e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CDA—breast cancer	5.03e-06	6.27e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	4.97e-06	6.19e-05	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—RAF1—breast cancer	4.93e-06	6.15e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	4.92e-06	6.13e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MAPK3—breast cancer	4.87e-06	6.08e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC2A5—breast cancer	4.84e-06	6.04e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLCO1B1—breast cancer	4.84e-06	6.04e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	4.73e-06	5.9e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TGFB1—breast cancer	4.73e-06	5.9e-05	CbGpPWpGaD
Tenofovir—NME2—Metabolism—AKT1—breast cancer	4.7e-06	5.86e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—APRT—breast cancer	4.68e-06	5.83e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	4.59e-06	5.72e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	4.57e-06	5.7e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ESRRA—breast cancer	4.4e-06	5.48e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ANGPTL4—breast cancer	4.4e-06	5.48e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—KRAS—breast cancer	4.38e-06	5.46e-05	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CA—breast cancer	4.36e-06	5.43e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	4.18e-06	5.21e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HADHB—breast cancer	4.17e-06	5.2e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GPI—breast cancer	4.17e-06	5.2e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CA—breast cancer	4.02e-06	5.02e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	3.99e-06	4.97e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALDH1A1—breast cancer	3.98e-06	4.96e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALDH7A1—breast cancer	3.98e-06	4.96e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	3.93e-06	4.9e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—breast cancer	3.89e-06	4.85e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—UMPS—breast cancer	3.81e-06	4.75e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PHGDH—breast cancer	3.81e-06	4.75e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ADSL—breast cancer	3.81e-06	4.75e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NME1—breast cancer	3.81e-06	4.75e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—FHL2—breast cancer	3.81e-06	4.75e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HPSE—breast cancer	3.74e-06	4.66e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—LDHB—breast cancer	3.74e-06	4.66e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—BRIP1—breast cancer	3.74e-06	4.66e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HRAS—breast cancer	3.72e-06	4.64e-05	CbGpPWpGaD
Tenofovir—NME1—Metabolism—AKT1—breast cancer	3.56e-06	4.44e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ABCC1—breast cancer	3.54e-06	4.42e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTA3—breast cancer	3.54e-06	4.42e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HMMR—breast cancer	3.54e-06	4.42e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PPARGC1B—breast cancer	3.43e-06	4.28e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	3.34e-06	4.17e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	3.34e-06	4.17e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—AKT1—breast cancer	3.29e-06	4.1e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CA9—breast cancer	3.24e-06	4.04e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTA4—breast cancer	3.24e-06	4.04e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	3.2e-06	3.99e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	3.17e-06	3.95e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GPX2—breast cancer	3.16e-06	3.94e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTA2—breast cancer	3.16e-06	3.94e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SULT1A1—breast cancer	3.12e-06	3.89e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GPX4—breast cancer	3.12e-06	3.89e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—IDH1—breast cancer	3.05e-06	3.8e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTA1—breast cancer	3.05e-06	3.8e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NAT2—breast cancer	3.01e-06	3.76e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.72e-06	3.4e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MED12—breast cancer	2.64e-06	3.3e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—DPYD—breast cancer	2.64e-06	3.3e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALDOA—breast cancer	2.6e-06	3.24e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NCOA3—breast cancer	2.53e-06	3.15e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC2A2—breast cancer	2.51e-06	3.13e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.48e-06	3.09e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MTR—breast cancer	2.46e-06	3.06e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CPT1A—breast cancer	2.46e-06	3.06e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ABCG2—breast cancer	2.46e-06	3.06e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HPGDS—breast cancer	2.41e-06	3e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HBA1—breast cancer	2.39e-06	2.99e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTT1—breast cancer	2.34e-06	2.91e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ACHE—breast cancer	2.34e-06	2.91e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP17A1—breast cancer	2.21e-06	2.76e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ENO1—breast cancer	2.19e-06	2.73e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS1—breast cancer	2.19e-06	2.73e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.18e-06	2.72e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.15e-06	2.69e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP2D6—breast cancer	2.15e-06	2.68e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NCOA2—breast cancer	2.11e-06	2.63e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—FASN—breast cancer	2.04e-06	2.55e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—BCHE—breast cancer	2.04e-06	2.54e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC5A5—breast cancer	2.01e-06	2.51e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NQO1—breast cancer	1.94e-06	2.42e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC2A1—breast cancer	1.94e-06	2.42e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.9e-06	2.37e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP3A4—breast cancer	1.89e-06	2.36e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.88e-06	2.35e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP1B1—breast cancer	1.86e-06	2.32e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.83e-06	2.28e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NCOA1—breast cancer	1.78e-06	2.21e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—STK11—breast cancer	1.75e-06	2.18e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP19A1—breast cancer	1.75e-06	2.18e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.64e-06	2.05e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—COMT—breast cancer	1.63e-06	2.03e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTP1—breast cancer	1.62e-06	2.02e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HMOX1—breast cancer	1.6e-06	1.99e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ITPR1—breast cancer	1.59e-06	1.99e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ABCB1—breast cancer	1.53e-06	1.91e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TYMS—breast cancer	1.51e-06	1.88e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NCOR1—breast cancer	1.49e-06	1.86e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.49e-06	1.86e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTM1—breast cancer	1.49e-06	1.86e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GPX1—breast cancer	1.43e-06	1.78e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP1A1—breast cancer	1.41e-06	1.76e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ERCC2—breast cancer	1.4e-06	1.75e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MTHFR—breast cancer	1.32e-06	1.64e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CAV1—breast cancer	1.21e-06	1.51e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.16e-06	1.45e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CG—breast cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CD—breast cancer	9.72e-07	1.21e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALB—breast cancer	9.59e-07	1.2e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NOS3—breast cancer	9.17e-07	1.14e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CB—breast cancer	8.47e-07	1.06e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS2—breast cancer	8.39e-07	1.05e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTEN—breast cancer	7.32e-07	9.13e-06	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CA—breast cancer	5.16e-07	6.44e-06	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKT1—breast cancer	4.22e-07	5.26e-06	CbGpPWpGaD
